Emens LA, Adams S, Barrios CH, Dieras V, et al. Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; 32: 983-993. Ann Oncol 2021 Nov 2. pii: S0923-7534(21)04520.
PMID: 34740469